{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:35:09Z","timestamp":1694630109794},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,8,10]],"date-time":"2007-08-10T00:00:00Z","timestamp":1186704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,8,10]],"date-time":"2007-08-10T00:00:00Z","timestamp":1186704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s10928-007-9067-z","type":"journal-article","created":{"date-parts":[[2007,8,9]],"date-time":"2007-08-09T17:00:55Z","timestamp":1186678855000},"page":"753-770","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mixed effects modeling of weight change associated with placebo and pregabalin administration"],"prefix":"10.1007","volume":"34","author":[{"given":"Bill","family":"Frame","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart L.","family":"Beal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannette","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,10]]},"reference":[{"key":"9067_CR1","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.1074\/jbc.271.10.5768","volume":"271","author":"NS Gee","year":"1996","unstructured":"Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R and Woodruff GN (1996). The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha-2-delta subunit of a calcium channel. J Biol Chem 271: 5768\u20135776","journal-title":"J Biol Chem"},{"key":"9067_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0028-3908(01)00172-1","volume":"42","author":"K Fink","year":"2002","unstructured":"Fink K, Dooley DJ, Meder WP, Suman-Chauhan N, Duffy S and Clusmann H (2002). Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 42: 229\u2013236","journal-title":"Neuropharmacology"},{"key":"9067_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0304-3940(00)00769-2","volume":"280","author":"DJ Dooley","year":"2000","unstructured":"Dooley DJ, Mieske CA and Borosky SA (2000). Inhibition of K+-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci Lett 280: 107\u2013110","journal-title":"Neurosci Lett"},{"key":"9067_CR4","first-page":"1086","volume":"295","author":"DJ Dooley","year":"2000","unstructured":"Dooley DJ, Donovan CM and Pugsley TA (2000). Stimulus-dependent modulation of [3H] nore- pinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther 295: 1086\u20131093","journal-title":"J Pharmacol Exp Ther"},{"key":"9067_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0304-3959(01)00316-5","volume":"93","author":"YP Maneuf","year":"2001","unstructured":"Maneuf YP, Hughes J and McKnight AT (2001). Gabapentin inhibits the substance P-facilitated K+-evoked release of [3H]glutamate from rat caudial trigeminal nucleus slices. Pain 93: 191\u2013196","journal-title":"Pain"},{"key":"9067_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0920-1211(02)00106-7","volume":"51","author":"M Bialer","year":"2002","unstructured":"Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P and Perucca E (2002). Progress report on new antiepileptic drugs: a summary of the sixth Eilat conference (EILAT VI). Epilepsy Res 51: 31\u201371","journal-title":"Epilepsy Res"},{"key":"9067_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0920-1211(93)90070-N","volume":"14","author":"CP Taylor","year":"1993","unstructured":"Taylor CP, Vartanian MG, Yuen PW, Bigge C, Suman-Chauhan N and Hill DR (1993). Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin. Epilepsy Res 14: 11\u201315","journal-title":"Epilepsy Res"},{"key":"9067_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1023\/A:1018951214146","volume":"10","author":"BH Stewart","year":"1993","unstructured":"Stewart BH, Kugler AR, Thompson PR and Bockbrader HN (1993). A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharm Res 10: 276\u2013281","journal-title":"Pharm Res"},{"key":"9067_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/00002826-199512000-00001","volume":"18","author":"A Beydoun","year":"1995","unstructured":"Beydoun A, Uthman BM and Sackellares JC (1995). Gabapentin: pharmacokinetics, efficacy, and safety. Clin Neuropharmacol 18: 469\u2013481","journal-title":"Clin Neuropharmacol"},{"key":"9067_CR10","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/01.WNL.0000068024.20285.65","volume":"60","author":"JA French","year":"2003","unstructured":"French JA, Kugler AR, Robbins JL, Knapp LE and Garofalo EA (2003). Dose\u2013response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 60: 1631\u20131637","journal-title":"Neurology"},{"key":"9067_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.0013-9580.2004.31203.x","volume":"45","author":"S Arroyo","year":"2004","unstructured":"Arroyo S, Anhut H, Kugler AR, Lee CM, Knapp LE and Garofalo EA (2004). Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose\u2013response study in adults with partial seizures. Epilepsia 45: 20\u201327","journal-title":"Epilepsia"},{"key":"9067_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/01.jcp.0000117423.05703.e7","volume":"24","author":"AC Pande","year":"2004","unstructured":"Pande AC, Feltner DE, Jefferson JW, Davidson JR, Pollack M and Stein MB (2004). Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. J Clin Psychopharmacol 24: 141\u2013149","journal-title":"J Clin Psychopharmacol"},{"key":"9067_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00004714-200306000-00005","volume":"23","author":"DE Feltner","year":"2003","unstructured":"Feltner DE, Crockatt JG, Dubovsky SJ, Cohn CK, Shrivastava RK and Targum SD (2003). A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol 23: 240\u2013249","journal-title":"J Clin Psychopharmacol"},{"key":"9067_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1176\/appi.ajp.160.3.533","volume":"160","author":"AC Pande","year":"2003","unstructured":"Pande AC, Crockatt JG, Feltner DE, Janney CA, Smith WT and Weisler R (2003). Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am J Psychiatry 160: 533\u2013540","journal-title":"Am J Psychiatry"},{"key":"9067_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pain.2004.01.001","volume":"109","author":"R Sabatowski","year":"2004","unstructured":"Sabatowski R, Galvez R, Cherry DA, Jacquot F, Vincent E and Maisonobe P (2004). Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 109: 26\u201335","journal-title":"Pain"},{"key":"9067_CR16","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","volume":"60","author":"RH Dworkin","year":"2003","unstructured":"Dworkin RH, Corbin AE, Sharma U, LaMoreaux L, Bockbrader H and Young JP (2003). Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60: 1274\u20131283","journal-title":"Neurology"},{"key":"9067_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1053\/eujp.2001.0235","volume":"5","author":"CM Hill","year":"2001","unstructured":"Hill CM, Balkenohl M, Thomas DW, Walker R, Mathe H and Murray G (2001). Pregabalin in patients with postoperative dental pain. Eur J Pain 5: 119\u2013124","journal-title":"Eur J Pain"},{"key":"9067_CR18","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1177\/106002809502901019","volume":"29","author":"BE Gidal","year":"1995","unstructured":"Gidal BE, Maly MM, Nemire RE and Haley K (1995). Weight gain and gabapentin therapy. Ann Pharmacother 29: 1048","journal-title":"Ann Pharmacother"},{"key":"9067_CR19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/00007691-199708000-00006","volume":"19","author":"JC DeToledo","year":"1997","unstructured":"DeToledo JC, Toledo C, DeCerce J and Ramsay RE (1997). Changes in body weight with chronic, high-dose gabapentin therapy. Ther Drug Monit 19: 394\u2013396","journal-title":"Ther Drug Monit"},{"key":"9067_CR20","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1046\/j.1528-1157.2002.01702.x","volume":"43","author":"LV Wilton","year":"2002","unstructured":"Wilton LV and Shakir S (2002). A postmarketing surveillance study of gabapentin as addon therapy for 3,100 patients in England. Epilepsia 43: 983\u2013992","journal-title":"Epilepsia"},{"key":"9067_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/sj.ijo.0800541","volume":"22","author":"KM Flegal","year":"1998","unstructured":"Flegal KM, Carroll MD, Kuczmarski RJ and Johnson CL (1998). Overweight and obesity in the United States: prevalence and trends, 1960\u20131994. Int J Obes Relat Metab Disord 22: 39\u201347","journal-title":"Int J Obes Relat Metab Disord"},{"key":"9067_CR22","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1001\/jama.282.16.1523","volume":"282","author":"A Must","year":"1999","unstructured":"Must A, Spadano J, Coakley EH, Field AE, Colditz G and Dietz WH (1999). The disease burden associated with overweight and obesity. JAMA 282: 1523\u20131529","journal-title":"JAMA"},{"key":"9067_CR23","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.1002\/j.1550-8528.1998.tb00690.x","volume":"6","author":"National Institutes of Health\/National Heart Lung and Blood Institute","year":"1998","unstructured":"National Institutes of Health\/National Heart Lung and Blood Institute (1998). Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: the evidence report. Obes Res 6: 51S\u2013209S","journal-title":"Obes Res"},{"key":"9067_CR24","first-page":"63","volume":"20","author":"RP Troiano","year":"1996","unstructured":"Troiano RP, Sobal J, Levitsky DA and Frongillo EA (1996). The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. Int J of Obes Relat Metab Disord 20: 63\u201375","journal-title":"Int J of Obes Relat Metab Disord"},{"key":"9067_CR25","doi-asserted-by":"crossref","DOI":"10.1002\/0471721182","volume-title":"Finite mixture models","author":"G McLachlan","year":"2000","unstructured":"McLachlan G and Peel D (2000). Finite mixture models. John Wiley, New York"},{"key":"9067_CR26","volume-title":"NONMEM users guide VII; conditional estimation methods","year":"1998","unstructured":"Beal SL, Sheiner LB (eds) (1998). NONMEM users guide VII; conditional estimation methods. Globomax Hanover, Maryland"},{"key":"9067_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000130554","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW and Gault MH (1976). Prediction of creatinine clearance from serum creatinine. Nephron 16: 31\u201341","journal-title":"Nephron"},{"key":"9067_CR28","unstructured":"Beal SL, Sheiner LB (eds) (1989\u20131998) NONMEM Users guides I\u2013VIII. Globomax, Hanover, Maryland"},{"key":"9067_CR29","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-2873-3","volume-title":"Transformation and weighting in regression","author":"RJ Carrol","year":"1988","unstructured":"Carrol RJ and Ruppert D (1988). Transformation and weighting in regression. Chapman and Hall, New York"},{"key":"9067_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10928-005-0090-7","volume":"32","author":"SL Beal","year":"2005","unstructured":"Beal SL (2005). Conditioning on certain random events associated with statistical variability in PK\/PD. J Pharmacokinet Pharmacodyn 32: 213\u2013243","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"9067_CR31","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.2307\/2533256","volume":"51","author":"KE Fattinger","year":"1995","unstructured":"Fattinger KE, Sheiner LB and Verotta D (1995). A new method to explore the distribution of interindividual random effects in nonlinear mixed effects models. Biometrics 51: 1236\u20131251","journal-title":"Biometrics"},{"key":"9067_CR32","volume-title":"Bayesian data analysis","author":"A Gelman","year":"2004","unstructured":"Gelman A, Carlin JB, Stern HS and Rubin DB (2004). Bayesian data analysis. Chapman and Hall\/CRC, Boca Raton"},{"key":"9067_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.0006-341X.2000.00065.x","volume":"56","author":"A Oberg","year":"2000","unstructured":"Oberg A and Davidian M (2000). Estimating data transformations in nonlinear mixed effects models. Biometrics 56: 65\u201372","journal-title":"Biometrics"},{"key":"9067_CR34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/00008571-200104000-00010","volume":"11","author":"CJ Hong","year":"2001","unstructured":"Hong CJ, Lin CH, Yu YWY, Yang KH and Tsai SJ (2001). Genetic variants in the serotonin system and weight change during clozapine treatment. Pharmacogenetics 11: 265\u2013268","journal-title":"Pharmacogenetics"},{"key":"9067_CR35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4088\/JCP.v62n0204","volume":"62","author":"BJ Kinon","year":"2001","unstructured":"Kinon BJ, Basson BR, Gilmore JA and Tollefson GD (2001). Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. J Clin Psychiatry 62: 92\u2013100","journal-title":"J Clin Psychiatry"},{"key":"9067_CR36","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4088\/JCP.v64n0314","volume":"64","author":"HY Lane","year":"2003","unstructured":"Lane HY, Chang YC, Cheng YC, Liu GC, Lin XR and Chang WH (2003). Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophrenia. J Clin Psychiatry 64: 316\u2013320","journal-title":"J Clin Psychiatry"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-007-9067-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10928-007-9067-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-007-9067-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-007-9067-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T21:43:32Z","timestamp":1652651012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10928-007-9067-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,10]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["9067"],"URL":"https:\/\/doi.org\/10.1007\/s10928-007-9067-z","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,10]]},"assertion":[{"value":"26 May 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}